1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
The Pathway to Prevention (P2P) for ME/CFS: A Dangerous Process
Gabby Klein gives an overview of the P2P process, shedding light on the pitfalls with advice as to what we can do in protest ...
Discuss the article on the Forums.

Overview of the Drug Development Landscape

Discussion in 'General ME/CFS News' started by lnester7, Mar 26, 2013.

  1. lnester7

    lnester7 Seven

    Messages:
    1,227
    Likes:
    1,102
    USA
    http://www.research1st.com/2013/03/18/upcoming-webinar-1/

    Date/Time: March 28, 2013 at 1:00 p.m. EDT
    Speaker: Kristin Schneeman, Program Director, FasterCures Host: Kim McCleary, CEO, The CFIDS Association of America
    Registration: http://bit.ly/spring-series-1

    In the first program of our Spring 2013 Webinar Series, we welcome Kristin Schneeman, program director for FasterCures, as our guest speaker. Kristin will outline the process to translate scientific discoveries into accessible medical solutions. She will define the major components of the research and development (R&D) cycle as a basis for helping community members understand the landscape for drug development. She will contrast it with the landscape for basic research, an area that is more familiar to most patient advocates and community members.

See more popular forum discussions.

Share This Page